Randomized, single-blind, parallel groups, controlled study to compare levofloxacin and prulifloxacin in patients with exacerbations of COPD previously treated with different antibiotics and admitted to Internal Medicine Departments.

Trial Profile

Randomized, single-blind, parallel groups, controlled study to compare levofloxacin and prulifloxacin in patients with exacerbations of COPD previously treated with different antibiotics and admitted to Internal Medicine Departments.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Prulifloxacin (Primary) ; Levofloxacin
  • Indications Bacterial infections; Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms FLOR
  • Most Recent Events

    • 11 Jan 2017 Status changed from recruiting to completed.
    • 18 Oct 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01710488).
    • 18 Oct 2012 Planned end date changed from 14 Apr 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top